VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has... by Varey, A, Rennel, E, Qiu, Y, Bevan, H, Perrin, R, Raffy, S, Dixon, A, Paraskeva, C, Zaccheo, O, Hassan, A, Harper, S, Bates, DO